• 1
    Bygbjerg IC. AIDS in a Danish surgeon (Zaire, 1976). Lancet 1983; 321: 925.
  • 2
    Antinori A, Coenen T, Costagiola Det al. Late presentation of HIV infection: a consensus definition. HIV Med 2011; 12: 6164.
  • 3
    European Centre for Disease Prevention and Control. HIV/AIDS Surveillance in Europe 2010. Stockholm, ECDC, 2011.
  • 4
    WHO, UNAIDS, GIZ, MSM GfF, UNDP. Prevention and Treatment of HIV and Other Sexually Transmitted Infections among Men Who Have Sex with Men and Transgender People: Recommendations for a Public Health Approach. Geneva, World Health Organization, 2011. Available at (accessed 28 June 2012).
  • 5
    Branson BM, Handsfield HH, Lampe MAet al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 2006; 55 (RR–14): 117. Available at (accessed 25 April 2012).
  • 6
    WHO, UNAIDS. Guidance on Provider-initiated HIV Testing and Counselling in Health Facilities. Geneva, World Health Organization, 2007. Available at (accessed 28 June 2012).
  • 7
    HIV in Europe Initiative. Proceedings of the 2012 Copenhagen Conference. Available at (accessed 28 June 2012).
  • 8
    HIV in Europe Initiative. HIV Indicator Conditions: Guidance for Implementing HIV Testing in Adults in Health Care Settings. Copenhagen, Copenhagen University, 2012.
  • 9
    Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA 1993; 269: 729730.
  • 10
    Paltiel AD, Weinstein MC, Kimmel ADet al. Expanded screening for HIV in the United States: an analysis of cost-effectiveness. N Engl J Med 2005; 352: 586595.
  • 11
    Sanders GD, Bayoumi AM, Sundaram Vet al. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy. N Engl J Med 2005; 352: 570585.
  • 12
    Sullivan A, Raben D, Reekie Jet al. Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV Indicator Diseases across Europe Study). PLoS ONE 2013; 8: e52845.
  • 13
    Egger M, May M, Chêne Get al.; ART Cohort Collaboration. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002; 360: 119129.
  • 14
    Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS 2006; 20: 14471450.
  • 15
    Fleishman JA, Yehia BR, Moore RD, Gebo KA, HIV Research Network. The economic burden of late entry into medical care for patients with HIV infection. Med Care 2010; 48: 10711079.